{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:53:09Z","timestamp":1793659989109,"version":"4.5.1"},"reference-count":108,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T00:00:00Z","timestamp":1610928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012041","name":"Versus Arthritis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Pulmonary manifestations of systemic lupus erythematosus (SLE) are wide-ranging and debilitating in nature. Previous studies suggest that anywhere between 20 and 90% of patients with SLE will be troubled by some form of respiratory involvement throughout the course of their disease. This can include disorders of the lung parenchyma (such as interstitial lung disease and acute pneumonitis), pleura (resulting in pleurisy and pleural effusion), and pulmonary vasculature [including pulmonary arterial hypertension (PAH), pulmonary embolic disease, and pulmonary vasculitis], whilst shrinking lung syndrome is a rare complication of the disease. Furthermore, the risks of respiratory infection (which often mimic acute pulmonary manifestations of SLE) are increased by the immunosuppressive treatment that is routinely used in the management of lupus. Although these conditions commonly present with a combination of dyspnea, cough and chest pain, it is important to consider that some patients may be asymptomatic with the only suggestion of the respiratory disorder being found incidentally on thoracic imaging or pulmonary function tests. Treatment decisions are often based upon evidence from case reports or small cases series given the paucity of clinical trial data specifically focused on pulmonary manifestations of SLE. Many therapeutic options are often initiated based on studies in severe manifestations of SLE affecting other organ systems or from experience drawn from the use of these therapeutics in the pulmonary manifestations of other systemic autoimmune rheumatic diseases. In this review, we describe the key features of the pulmonary manifestations of SLE and approaches to investigation and management in clinical practice.<\/jats:p>","DOI":"10.3389\/fmed.2020.610257","type":"journal-article","created":{"date-parts":[[2021,1,17]],"date-time":"2021-01-17T23:33:21Z","timestamp":1610926401000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":86,"title":["Lupus and the Lungs: The Assessment and Management of Pulmonary Manifestations of Systemic Lupus Erythematosus"],"prefix":"10.3389","volume":"7","author":[{"given":"Raj","family":"Amarnani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Ann","family":"Yeoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma K.","family":"Denneny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Wincup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s12016-017-8640-5","article-title":"Unmet needs in the pathogenesis and treatment of systemic lupus erythematosus","volume":"55","author":"Bakshi","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.rdc.2009.03.003","article-title":"Pathophysiology and clinical spectrum of infections in systemic lupus erythematosus","volume":"35","author":"Cuchacovich","year":"2009","journal-title":"Rheum Dis Clin North Am"},{"key":"B3","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/resp.12473","article-title":"Pulmonary manifestations in systemic lupus erythematosus: association with disease activity","volume":"20","author":"Alamoudi","year":"2015","journal-title":"Respirology"},{"key":"B4","first-page":"455","article-title":"Dyspnea in ambulatory patients with SLE: prevalence, severity, and correlation with incremental exercise testing","volume":"22","author":"Hellman","year":"1995","journal-title":"J Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1046\/j.1440-1843.2002.00361.x","article-title":"Pulmonary diffusion capacity in patients with systemic lupus erythematosus","volume":"7","author":"Nakano","year":"2002","journal-title":"Respirology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.reuma.2018.03.012","article-title":"Pulmonary manifestations in systemic lupus erythematosus: pleural involvement, acute pneumonitis, chronic interstitial lung disease and diffuse alveolar hemorrhage","volume":"14","author":"Aguilera-Pickens","year":"2018","journal-title":"Reumatol Clin"},{"key":"B7","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2174\/1573397113666170704102444","article-title":"Cardiovascular and pulmonary manifestations of systemic lupus erythematosus","volume":"13","author":"Tselios","year":"2017","journal-title":"Curr Rheumatol Rev"},{"key":"B8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1055\/s-0039-1685537","article-title":"Pulmonary complications of systemic lupus erythematosus","volume":"40","author":"Hannah","year":"2019","journal-title":"Semin Respir Crit Care Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1177\/0961203307079042","article-title":"Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damage","volume":"16","author":"Bertoli","year":"2007","journal-title":"Lupus"},{"key":"B10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.ccm.2010.05.001","article-title":"Pulmonary manifestations of systemic lupus erythematosus","volume":"31","author":"Kamen","year":"2010","journal-title":"Clin Chest Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1177\/0961203316630818","article-title":"Impact of pulmonary disease on patient-reported outcomes and patient-performed functional testing in systemic lupus erythematosus","volume":"25","author":"Fidler","year":"2016","journal-title":"Lupus"},{"key":"B12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/0049-0172(90)90094-V","article-title":"A long-term study of interstitial lung disease in systemic lupus erythematosus","volume":"20","author":"Weinrib","year":"1990","journal-title":"Semin Arthritis Rheum"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005382-199203000-00003","article-title":"Pulmonary manifestations of systemic lupus erythematosus","volume":"7","author":"Wiedemann","year":"1992","journal-title":"J Thorac Imaging"},{"key":"B14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.7326\/0003-4819-79-1-37","article-title":"Diffuse interstitial lung disease in systemic lupus erythematosus","volume":"79","author":"Eisenberg","year":"1973","journal-title":"Ann Intern Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"h6819","DOI":"10.1136\/bmj.h6819","article-title":"Management of interstitial lung disease associated with connective tissue disease","volume":"352","author":"Mathai","year":"2016","journal-title":"BMJ"},{"key":"B16","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/0049-0172(90)90057-M","article-title":"Clinical associations of antiribonucleoprotein antibodies in patients with systemic lupus erythematosus","volume":"20","author":"ter Borg","year":"1990","journal-title":"Semin Arthritis Rheum"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1002\/anr.1780321007","article-title":"A meta-analysis of the clinical manifestations of older-onset systemic lupus erythematosus","volume":"32","author":"Ward","year":"1989","journal-title":"Arthritis Rheum"},{"key":"B18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/01.cpm.0000197403.64631.de","article-title":"Collagen vascular diseases of the lung","volume":"13","author":"Frankel","year":"2006","journal-title":"Clin Pulm Med"},{"key":"B19","first-page":"2254","article-title":"Bronchiolitis obliterans organizing pneumonia as an initial manifestation in patients with systemic lupus erythematosus","volume":"24","author":"Min","year":"1997","journal-title":"J Rheumatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1365-2559.2004.01896.x","article-title":"Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis","volume":"44","author":"Tansey","year":"2004","journal-title":"Histopathology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1177\/096120339500400217","article-title":"Lymphocytic interstitial pneumonitis in a patient with systemic lupus erythematosus","volume":"4","author":"Yood","year":"1995","journal-title":"Lupus"},{"key":"B22","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1097\/00063198-200009000-00007","article-title":"Interstitial lung disease in systemic lupus erythematosus","volume":"6","author":"Cheema","year":"2000","journal-title":"Curr Opin Pulm Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2214\/ajr.166.2.8553934","article-title":"High-resolution chest CT in systemic lupus erythematosus","volume":"166","author":"Fenlon","year":"1996","journal-title":"AJR Am J Roentgenol"},{"key":"B24","first-page":"4233","article-title":"Clinical features and independent predictors of interstitial lung disease in systemic lupus erythematosus","volume":"9","author":"Lian","year":"2016","journal-title":"Int J Clin Exp Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.rdc.2014.12.002","article-title":"Histopathology of lung disease in the connective tissue diseases","volume":"41","author":"Vivero","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"key":"B26","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/art.1780370318","article-title":"Treatment of lupus interstitial lung disease with intravenous cyclophosphamide","volume":"37","author":"Eiser","year":"1994","journal-title":"Arthritis Rheum"},{"key":"B27","first-page":"967","article-title":"Successful treatment of interstitial lung disease in systemic lupus erythematosus with methotrexate","volume":"22","author":"Fink","year":"1995","journal-title":"J Rheumatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1445-5994.2006.01055.x","article-title":"Rituximab use in systemic lupus erythematosus pneumonitis and a review of current reports","volume":"36","author":"Lim","year":"2006","journal-title":"Intern Med J"},{"key":"B29","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3109\/s10165-007-0554-2","article-title":"Intermittent intravenous cyclophosphamide pulse therapy for the treatment of active interstitial lung disease associated with collagen vascular diseases","volume":"17","author":"Okada","year":"2007","journal-title":"Mod Rheumatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3904\/kjim.2016.212","article-title":"Treatment of connective tissue disease-associated interstitial lung disease: the pulmonologist's point of view","volume":"32","author":"Koo","year":"2017","journal-title":"Korean J Intern Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/S0012-3692(15)50949-5","article-title":"Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease","volume":"130","author":"Swigris","year":"2006","journal-title":"Chest"},{"key":"B32","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/thorax.55.2.159","article-title":"Pleuropulmonary manifestations of systemic lupus erythematosus","volume":"55","author":"Keane","year":"2000","journal-title":"Thorax"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1177\/0961203316646461","article-title":"Lupus pneumonitis as the initial presentation of systemic lupus erythematosus: case series from a single institution","volume":"25","author":"Wan","year":"2016","journal-title":"Lupus"},{"key":"B34","first-page":"495","article-title":"Treatment of systemic lupus erythematosus by prolonged administration of high dose intravenous immunoglobulin: report of 2 cases","volume":"20","author":"Winder","year":"1993","journal-title":"J Rheumatol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1177\/0961203314548713","article-title":"Acute respiratory distress syndrome in a pregnant woman with systemic lupus erythematosus: a case report","volume":"23","author":"Chen","year":"2014","journal-title":"Lupus"},{"key":"B36","first-page":"479","article-title":"Lupus pneumonitis and anti-SSA(Ro) antibodies","volume":"16","author":"Boulware","year":"1989","journal-title":"J Rheumatol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.berh.2009.01.002","article-title":"Respiratory manifestations of systemic lupus erythematosus: old and new concepts","volume":"23","author":"Pego-Reigosa","year":"2009","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1097\/00063198-200207000-00012","article-title":"Diagnosis and management of lupus pleuritis","volume":"8","author":"Wang","year":"2002","journal-title":"Curr Opin Pulm Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1378\/chest.84.6.714","article-title":"Lupus pleuritis. Clinical features and pleural fluid characteristics with special reference to pleural fluid antinuclear antibodies","volume":"84","author":"Good","year":"1983","journal-title":"Chest"},{"key":"B40","first-page":"471","article-title":"Pulmonary involvement in the collagen vascular diseases","volume":"119","author":"Hunninghake","year":"1979","journal-title":"Am Rev Respir Dis"},{"key":"B41","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1378\/chest.88.1.129","article-title":"Pleuro-pulmonary manifestations of systemic lupus erythematosus: clinical features of its subgroups. Prognostic and therapeutic implications","volume":"88","author":"Pines","year":"1985","journal-title":"Chest"},{"key":"B42","doi-asserted-by":"publisher","first-page":"884A","DOI":"10.1378\/chest.2236839","article-title":"Drug induced lupus presenting as isolated pleural effusion","volume":"148","author":"Ajakumar Menon","year":"2015","journal-title":"Chest"},{"key":"B43","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.semarthrit.2007.08.003","article-title":"Drug-induced lupus due to anti-tumor necrosis factor alpha agents","volume":"37","author":"Costa","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"B44","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1378\/chest.101.1.268","article-title":"Drug-induced lupus pleuritis mimicking pleural space infection","volume":"101","author":"Smith","year":"1992","journal-title":"Chest"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1378\/chest.117.5.1404","article-title":"Successful talc slurry pleurodesis in patients with nonmalignant pleural effusion","volume":"117","author":"Glazer","year":"2000","journal-title":"Chest"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1002\/art.1780341121","article-title":"Successful use of tetracycline pleurodesis to treat massive pleural effusion secondary to systemic lupus erythematosus","volume":"34","author":"McKnight","year":"1991","journal-title":"Arthritis Rheum"},{"key":"B47","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3238\/arztebl.2016.0073","article-title":"Pulmonary hypertension","volume":"114","author":"Hoeper","year":"2017","journal-title":"Dtsch Arztebl Int"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/OARRR.S123549","article-title":"Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategies","volume":"9","author":"Tselios","year":"2016","journal-title":"Open Access Rheumatol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1191\/0961203303lu1051oa","article-title":"Pulmonary hypertension in systemic lupus","volume":"13","author":"Johnson","year":"2004","journal-title":"Lupus"},{"key":"B50","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1191\/096120300678828361","article-title":"Primary and secondary pulmonary hypertension in systemic lupus erythematosus","volume":"9","author":"Pan","year":"2000","journal-title":"Lupus"},{"key":"B51","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/0049-0172(84)90015-5","article-title":"Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus","volume":"13","author":"Quismorio","year":"1984","journal-title":"Semin Arthritis Rheum"},{"key":"B52","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s002960050074","article-title":"Pulmonary hypertension in systemic lupus erythematosus","volume":"18","author":"Shen","year":"1999","journal-title":"Rheumatol Int"},{"key":"B53","first-page":"918","article-title":"Pulmonary hypertension in systemic lupus erythematosus","volume":"16","author":"Simonson","year":"1989","journal-title":"J Rheumatol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/0002-8703(95)90278-3","article-title":"Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus","volume":"129","author":"Winslow","year":"1995","journal-title":"Am Heart J"},{"key":"B55","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s11845-017-1727-4","article-title":"Prevalence of pulmonary hypertension in systemic lupus erythematosus: a meta-analysis","volume":"187","author":"Lv","year":"2018","journal-title":"Ir J Med Sci"},{"key":"B56","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1177\/0961203307087188","article-title":"An update in pulmonary hypertension in systemic lupus erythematosus - do we need to know about it?","volume":"17","author":"Pope","year":"2008","journal-title":"Lupus"},{"key":"B57","doi-asserted-by":"publisher","first-page":"854941","DOI":"10.1155\/2012\/854941","article-title":"Pulmonary arterial hypertension in systemic lupus erythematosus: current status and future direction","volume":"2012","author":"Dhala","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"D42","DOI":"10.1016\/j.jacc.2013.10.032","article-title":"Definitions and diagnosis of pulmonary hypertension","volume":"62","author":"Hoeper","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"B59","first-page":"2417","article-title":"Sildenafil for pulmonary arterial hypertension associated with connective tissue disease","volume":"34","author":"Badesch","year":"2007","journal-title":"J Rheumatol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1177\/0961203307076509","article-title":"Bosentan use in systemic lupus erythematosus patients with pulmonary arterial hypertension","volume":"16","author":"Mok","year":"2007","journal-title":"Lupus"},{"key":"B61","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1378\/chest.126.2.420","article-title":"Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease","volume":"126","author":"Oudiz","year":"2004","journal-title":"Chest"},{"key":"B62","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1378\/chest.117.1.14","article-title":"Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus","volume":"117","author":"Robbins","year":"2000","journal-title":"Chest"},{"key":"B63","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N Engl J Med"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.3109\/s10165-012-0828-1","article-title":"Intravenous epoprostenol treatment of patients with connective tissue disease and pulmonary arterial hypertension at a single center","volume":"23","author":"Shirai","year":"2013","journal-title":"Mod Rheumatol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1136\/annrheumdis-2015-209087","article-title":"Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2","volume":"76","author":"Humbert","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e4327","DOI":"10.7759\/cureus.4327","article-title":"Systemic sclerosis and systemic lupus erythematosus overlap syndrome with pulmonary arterial hypertension successfully treated with immunosuppressive therapy and riociguat","volume":"11","author":"Kuzuya","year":"2019","journal-title":"Cureus"},{"key":"B67","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1191\/0961203304lu509oa","article-title":"Therapy with intermittent pulse cyclophosphamide for pulmonary hypertension associated with systemic lupus erythematosus","volume":"13","author":"Gonzalez-Lopez","year":"2004","journal-title":"Lupus"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1093\/rheumatology\/kev097","article-title":"Pulmonary arterial hypertension in systemic lupus erythematosus may benefit by addition of immunosuppression to vasodilator therapy: an observational study","volume":"54","author":"Kommireddy","year":"2015","journal-title":"Rheumatology."},{"key":"B69","first-page":"267","article-title":"Severe pulmonary hypertension as the initial manifestation of systemic lupus erythematosus: a case report and review of the literature","volume":"32","author":"Prete","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"B70","first-page":"282","article-title":"Pulmonary hypertension in systemic lupus erythematosus: evaluation of clinical characteristics and response to immunosuppressive treatment","volume":"29","author":"Tanaka","year":"2002","journal-title":"J Rheumatol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1177\/0961203307087610","article-title":"Rituximab treatment of pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report","volume":"17","author":"Hennigan","year":"2008","journal-title":"Lupus"},{"key":"B72","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1177\/096120339700600510","article-title":"Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus\u2014a meta-analysis","volume":"6","author":"Wahl","year":"1997","journal-title":"Lupus"},{"key":"B73","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/acr.22684","article-title":"Utility and associated risk of pulmonary embolism computed tomography scans in the michigan lupus cohort","volume":"68","author":"Kado","year":"2016","journal-title":"Arthritis Care Res"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1182\/blood-2018-04-848333","article-title":"Rivaroxaban vs. warfarin in high-risk patients with antiphospholipid syndrome","volume":"132","author":"Pengo","year":"2018","journal-title":"Blood"},{"key":"B75","first-page":"558","article-title":"Fatal pulmonary hemorrhage in systemic lupus erythematosus. Occurrence without hemoptysis","volume":"12","author":"Abud-Mendoza","year":"1985","journal-title":"J Rheumatol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/00005792-199705000-00005","article-title":"Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome","volume":"76","author":"Zamora","year":"1997","journal-title":"Medicine"},{"key":"B77","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1055\/s-0031-1279827","article-title":"Alveolar hemorrhage in vasculitis: primary and secondary","volume":"32","author":"Cordier","year":"2011","journal-title":"Semin Respir Crit Care Med"},{"key":"B78","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.semarthrit.2014.10.013","article-title":"Antiphospholipid antibodies-associated diffuse alveolar hemorrhage","volume":"44","author":"Yachoui","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1378\/chest.118.4.1083","article-title":"Alveolar hemorrhage in systemic lupus erythematosus: presentation and management","volume":"118","author":"Santos-Ocampo","year":"2000","journal-title":"Chest"},{"key":"B80","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1177\/096120339700600906","article-title":"Pulmonary haemorrhage in Oriental patients with systemic lupus erythematosus","volume":"6","author":"Koh","year":"1997","journal-title":"Lupus"},{"key":"B81","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3889\/oamjms.2019.038","article-title":"Predictors of mortality in pulmonary haemorrhage during SLE: a single centre study over eleven years","volume":"7","author":"Masoodi","year":"2019","journal-title":"Open Access Maced J Med Sci"},{"key":"B82","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11926-017-0651-y","article-title":"Diffuse alveolar hemorrhage in autoimmune diseases","volume":"19","author":"Mart\u00ednez-Mart\u00ednez","year":"2017","journal-title":"Curr Rheumatol Rep"},{"key":"B83","doi-asserted-by":"publisher","first-page":"e4626","DOI":"10.1097\/MD.0000000000004626","article-title":"Shrinking lung syndrome in systemic lupus erythematosus: a case series and review of the literature","volume":"95","author":"Borrell","year":"2016","journal-title":"Medicine."},{"key":"B84","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1177\/0961203317722411","article-title":"Shrinking lung syndrome in systemic lupus erythematosus: a single-centre experience","volume":"27","author":"Deeb","year":"2018","journal-title":"Lupus"},{"key":"B85","first-page":"429","article-title":"Diaphragm strength in the shrinking lung syndrome of systemic lupus erythematosus","volume":"71","author":"Laroche","year":"1989","journal-title":"Q J Med"},{"key":"B86","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.semarthrit.2008.04.003","article-title":"Association of the shrinking lung syndrome in systemic lupus erythematosus with pleurisy: a systematic review","volume":"39","author":"Toya","year":"2009","journal-title":"Semin Arthritis Rheum"},{"key":"B87","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1053\/sarh.2002.32555","article-title":"Presentation and prognosis of the shrinking lung syndrome in systemic lupus erythematosus","volume":"31","author":"Karim","year":"2002","journal-title":"Semin Arthritis Rheum"},{"key":"B88","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.autrev.2016.07.021","article-title":"Shrinking lung syndrome associated with systemic lupus erythematosus: a multicenter collaborative study of 15 new cases and a review of the 155 cases in the literature focusing on treatment response and long-term outcomes","volume":"15","author":"Duron","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B89","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/RHU.0b013e3181d0757f","article-title":"Successful treatment of shrinking lung syndrome with rituximab in a patient with systemic lupus erythematosus","volume":"16","author":"Benham","year":"2010","journal-title":"J Clin Rheumatol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1159\/000334947","article-title":"Shrinking lung syndrome successfully treated with rituximab and cyclophosphamide","volume":"84","author":"Langenski\u00f6ld","year":"2012","journal-title":"Respiration"},{"key":"B91","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.reuma.2013.09.003","article-title":"Rituximab in the treatment of shrinking lung syndrome in systemic lupus erythematosus","volume":"10","author":"Pe\u00f1acoba Toribio","year":"2014","journal-title":"Reumatol Clin"},{"key":"B92","first-page":"1970","article-title":"The \u201cshrinking lungs syndrome\u201d in systemic lupus erythematosus\u2013improvement with corticosteroid therapy","volume":"19","author":"Walz-Leblanc","year":"1992","journal-title":"J Rheumatol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1378\/chest.127.5.1680","article-title":"Prevalence and reversibility of pulmonary dysfunction in refractory systemic lupus: improvement correlates with disease remission following hematopoietic stem cell transplantation","volume":"127","author":"Traynor","year":"2005","journal-title":"Chest"},{"key":"B94","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1177\/096120339700600413","article-title":"Shrinking lungs syndrome in systemic lupus erythematosus: improvement with inhaled beta-agonist therapy","volume":"6","author":"Mu\u00f1oz-Rodr\u00edguez","year":"1997","journal-title":"Lupus"},{"key":"B95","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/BF02231771","article-title":"The \u201cshrinking lung syndrome\u201d in SLE, treatment with theophylline","volume":"12","author":"Van Veen","year":"1993","journal-title":"Clin Rheumatol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1097\/01.mcp.0000170522.71497.61","article-title":"Autoimmunity and interstitial lung disease","volume":"11","author":"Jindal","year":"2005","journal-title":"Curr Opin Pulm Med"},{"key":"B97","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0889-857X(21)00230-1","article-title":"Pleuropulmonary manifestations of systemic lupus erythematosus","volume":"20","author":"Orens","year":"1994","journal-title":"Rheum Dis Clin North Am"},{"key":"B98","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1093\/ajcp\/85.5.552","article-title":"Microangiitis in lupus-induced pulmonary hemorrhage","volume":"85","author":"Myers","year":"1986","journal-title":"Am J Clin Pathol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1136\/ard.49.3.160","article-title":"Autoantibody and idiotype profile of lung involvement in autoimmune rheumatic disease","volume":"49","author":"Turner-Stokes","year":"1990","journal-title":"Ann Rheum Dis"},{"key":"B100","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1002\/art.1780190526","article-title":"Letter: In vivo LE phenomenon in pleural fluid","volume":"19","author":"Pandya","year":"1976","journal-title":"Arthritis Rheum"},{"key":"B101","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.humpath.2006.11.022","article-title":"Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases","volume":"38","author":"Dorfm\u00fcller","year":"2007","journal-title":"Hum Pathol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1586\/ers.10.84","article-title":"Shrinking lung syndrome: recognition, pathophysiology and therapeutic strategy","volume":"5","author":"Carmier","year":"2011","journal-title":"Expert Rev Respir Med"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/rheumatology\/kep064","article-title":"The BILAG-2004 index is sensitive to change for assessment of SLE disease activity","volume":"48","author":"Yee","year":"2009","journal-title":"Rheumatology"},{"key":"B106","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1136\/annrheumdis-2015-207726","article-title":"Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)","volume":"75","author":"Franklyn","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B108","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/art.1780390303","article-title":"The development and initial validation of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology damage index for systemic lupus erythematosus","volume":"39","author":"Gladman","year":"1996","journal-title":"Arthritis Rheum"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2020.610257\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T18:36:20Z","timestamp":1670783780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2020.610257\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,18]]},"references-count":108,"alternative-id":["10.3389\/fmed.2020.610257"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2020.610257","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,18]]},"article-number":"610257"}}